交易 IGM Biosciences, Inc. - IGMS CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
IGM Biosciences Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 19, 2024 | 7.17 | -0.04 | -0.55% | 7.21 | 7.37 | 7.01 |
Apr 18, 2024 | 7.37 | -0.61 | -7.64% | 7.98 | 8.05 | 7.07 |
Apr 17, 2024 | 8.07 | -0.91 | -10.13% | 8.98 | 9.31 | 8.02 |
Apr 16, 2024 | 9.18 | 0.01 | 0.11% | 9.17 | 9.43 | 8.90 |
Apr 15, 2024 | 9.37 | 0.50 | 5.64% | 8.87 | 9.72 | 8.87 |
Apr 12, 2024 | 9.16 | 0.90 | 10.90% | 8.26 | 9.23 | 8.22 |
Apr 11, 2024 | 8.34 | 0.18 | 2.21% | 8.16 | 8.34 | 7.92 |
Apr 10, 2024 | 8.14 | -0.34 | -4.01% | 8.48 | 8.51 | 7.90 |
Apr 9, 2024 | 8.72 | 0.10 | 1.16% | 8.62 | 9.01 | 8.59 |
Apr 8, 2024 | 8.74 | 0.00 | 0.00% | 8.74 | 9.09 | 8.56 |
Apr 5, 2024 | 8.74 | 0.06 | 0.69% | 8.68 | 9.04 | 8.53 |
Apr 4, 2024 | 8.86 | -0.12 | -1.34% | 8.98 | 9.44 | 8.82 |
Apr 3, 2024 | 9.01 | 0.03 | 0.33% | 8.98 | 9.19 | 8.57 |
Apr 2, 2024 | 9.12 | -0.11 | -1.19% | 9.23 | 9.32 | 8.80 |
Apr 1, 2024 | 9.43 | -1.19 | -11.21% | 10.62 | 10.62 | 9.29 |
Mar 28, 2024 | 9.57 | 0.45 | 4.93% | 9.12 | 9.67 | 9.12 |
Mar 27, 2024 | 9.25 | 0.57 | 6.57% | 8.68 | 9.38 | 8.52 |
Mar 26, 2024 | 8.64 | -0.09 | -1.03% | 8.73 | 8.76 | 8.14 |
Mar 25, 2024 | 8.67 | -1.32 | -13.21% | 9.99 | 10.49 | 8.54 |
Mar 22, 2024 | 10.27 | 0.28 | 2.80% | 9.99 | 10.55 | 9.95 |
IGM Biosciences, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Friday, May 10, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 IGM Biosciences Inc Earnings Release Q1 2024 IGM Biosciences Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 21, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 IGM Biosciences Inc Annual Shareholders Meeting IGM Biosciences Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, August 1, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 IGM Biosciences Inc Earnings Release Q2 2024 IGM Biosciences Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.069 | 0 | 0 | 0 | 0 |
總營業費用 | 229.025 | 165.323 | 83.28 | 44.498 | 22.791 |
銷售/一般/行政費用,總計 | 49.736 | 38.297 | 18.25 | 9.241 | 3.829 |
研究與開發 | 179.289 | 127.026 | 65.03 | 35.257 | 18.962 |
營業收入 | -227.956 | -165.323 | -83.28 | -44.498 | -22.791 |
其他,淨值 | -0.181 | 0.159 | 1.925 | 1.365 | 0.08 |
稅前淨收入 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
稅後淨收入 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
未計算非常項目前的淨收益 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
淨收入 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
普通股股東可獲收益 (不含非經常性項目) | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
普通股股東可獲收益 (含非經常性項目) | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
攤薄淨收入 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
攤薄後加權平均股 | 41.5439 | 33.4798 | 30.7483 | 30.4851 | 28.892 |
扣除特別項目的每股攤薄盈利 | -5.32212 | -4.93325 | -2.64584 | -1.41489 | -0.78607 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -5.32212 | -4.93325 | -2.64584 | -1.41489 | -0.78607 |
收入 | 1.069 | ||||
利息收入(費用),非經營淨值 | 7.035 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.448 | 0.522 | 0.372 | 0.331 | 0.366 |
總營業費用 | 68.656 | 63.896 | 56.636 | 60.843 | 59.59 |
銷售/一般/行政費用,總計 | 12.983 | 13.002 | 11.619 | 12.664 | 12.372 |
研究與開發 | 55.673 | 50.894 | 45.017 | 48.179 | 47.218 |
營業收入 | -68.208 | -63.374 | -56.264 | -60.512 | -59.224 |
其他,淨值 | 0 | -0.02 | -0.058 | 0 | 0.629 |
稅前淨收入 | -64.314 | -59.222 | -52.576 | -58.037 | -58.595 |
稅後淨收入 | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
未計算非常項目前的淨收益 | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
淨收入 | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
普通股股東可獲收益 (不含非經常性項目) | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
普通股股東可獲收益 (含非經常性項目) | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
攤薄淨收入 | -64.423 | -59.309 | -52.576 | -58.037 | -58.595 |
攤薄後加權平均股 | 45.1229 | 44.5932 | 44.2711 | 44.0346 | 43.9191 |
扣除特別項目的每股攤薄盈利 | -1.42772 | -1.33 | -1.18759 | -1.31798 | -1.33416 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.42772 | -1.33 | -1.18759 | -1.31798 | -1.33416 |
收入 | 0.448 | 0.522 | 0.372 | 0.331 | 0.366 |
利息收入(費用),非經營淨值 | 3.894 | 4.172 | 3.746 | 2.475 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 438.421 | 240.747 | 373.272 | 231.1 | 2.407 |
現金和短期投資 | 427.162 | 229.542 | 366.269 | 224.634 | 1.887 |
現金等價物 | 121.231 | 133.334 | 241.08 | 35.891 | 1.887 |
應收賬款總額,淨額 | 0.035 | 0.035 | |||
預付的費用 | 10.57 | 10.504 | 7.003 | 6.431 | 0.485 |
總資産 | 513.499 | 298.127 | 408.632 | 261.35 | 3.979 |
物業/廠房/設備,總計 - 淨額 | 73.075 | 56.344 | 34.812 | 18.019 | 1.472 |
物業/廠房/設備,總計 - 總額 | 85.4 | 62.897 | 37.101 | 19.283 | 2.139 |
累計折舊,總計 | -12.325 | -6.553 | -2.289 | -1.264 | -0.667 |
其他長期資産,總計 | 2.003 | 1.036 | 0.548 | 0.258 | 0.1 |
流動負債總額 | 44.685 | 27.78 | 17.24 | 8.875 | 8.89 |
應付賬款 | 2.512 | 5.584 | 7.924 | 3.087 | 0.164 |
預提費用 | 39.437 | 22.196 | 9.316 | 5.788 | 3.582 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 5.027 |
其他流動負債,總計 | 2.736 | 0 | 0.117 | ||
負債總額 | 226.236 | 53.219 | 26.817 | 21.119 | 8.89 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 181.551 | 25.439 | 9.577 | 12.244 | 0 |
股權 | 287.263 | 244.908 | 381.815 | 240.231 | -4.911 |
Preferred Stock - Non Redeemable, Net | 60.917 | ||||
普通股 | 0.431 | 0.325 | 0.319 | 0.304 | 0.004 |
額外實收資本 | 862.359 | 598.373 | 570.03 | 347.089 | 0.751 |
留存收益(累計赤字) | -574.826 | -353.724 | -188.56 | -107.205 | -64.072 |
其他權益,總計 | 0.043 | -2.511 | |||
總負債和股東權益 | 513.499 | 298.127 | 408.632 | 261.35 | 3.979 |
已發行普通股總數 | 43.0823 | 32.498 | 31.9741 | 36.6957 | 28.892 |
短期投資 | 305.931 | 96.208 | 125.189 | 188.743 | |
長期投資 | 11.973 | ||||
Unrealized Gain (Loss) | -0.701 | -0.066 | 0.026 | ||
其他流動資産,總計 | 0.689 | 0.701 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 398.395 | 401.76 | 384.756 | 438.421 | 479.966 |
現金和短期投資 | 386.991 | 386.869 | 373.396 | 427.162 | 469.139 |
現金等價物 | 174.794 | 150.702 | 140.164 | 121.231 | 177.414 |
短期投資 | 212.197 | 236.167 | 233.232 | 305.931 | 291.725 |
預付的費用 | 10.787 | 14.249 | 10.702 | 10.57 | 10.134 |
總資産 | 474.35 | 480.658 | 462.742 | 513.499 | 540.936 |
物業/廠房/設備,總計 - 淨額 | 73.972 | 76.779 | 75.829 | 73.075 | 58.847 |
物業/廠房/設備,總計 - 總額 | |||||
累計折舊,總計 | |||||
其他長期資産,總計 | 1.983 | 2.119 | 2.157 | 2.003 | 2.123 |
流動負債總額 | 42.965 | 44.299 | 43.632 | 44.685 | 44.484 |
應付賬款 | 3.913 | 4.936 | 3.972 | 2.512 | 2.731 |
預提費用 | 34.139 | 34.618 | 36.063 | 39.437 | 36.996 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 220.488 | 222.051 | 223.312 | 226.236 | 212.761 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 177.523 | 177.752 | 179.68 | 181.551 | 168.277 |
股權 | 253.862 | 258.607 | 239.43 | 287.263 | 328.175 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
普通股 | 0.584 | 0.528 | 0.432 | 0.431 | 0.428 |
額外實收資本 | 1014.1 | 957.089 | 873.48 | 862.359 | 850.772 |
留存收益(累計赤字) | -760.547 | -698.558 | -634.135 | -574.826 | -522.25 |
Unrealized Gain (Loss) | -0.277 | -0.452 | -0.347 | -0.701 | -0.775 |
總負債和股東權益 | 474.35 | 480.658 | 462.742 | 513.499 | 540.936 |
已發行普通股總數 | 58.3852 | 52.7394 | 43.188 | 43.0823 | 42.8024 |
長期投資 | |||||
其他流動資産,總計 | 0.617 | 0.642 | 0.658 | 0.689 | 0.693 |
其他流動負債,總計 | 4.913 | 4.745 | 3.597 | 2.736 | 4.757 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 |
經營活動産生的現金 | -5.853 | -124.982 | -67.881 | -45.116 | -20.044 |
經營活動産生的現金 | 6.075 | 4.484 | 1.025 | 0.597 | 0.278 |
非現金物品 | 54.004 | 29.251 | 10.404 | 2.444 | 0.21 |
營運資金的變化 | 155.17 | 6.447 | 2.045 | -5.024 | 2.179 |
投資活動産生的現金 | -225.644 | 15.461 | 58.289 | -203.238 | -0.788 |
資本支出 | -10.206 | -13.244 | -17.502 | -2.337 | -0.788 |
融資活動産生的現金 | 219.382 | 2.476 | 214.781 | 282.258 | 22.337 |
融資現金流項目 | 0.895 | -0.65 | -1.048 | -2.094 | 0 |
股票的發行(報廢),淨額 | 218.487 | 3.126 | 215.829 | 269.352 | 17.337 |
債務的發行(退還),淨額 | 15 | 5 | |||
現金淨變化 | -12.115 | -107.045 | 205.189 | 33.904 | 1.505 |
Cash Taxes Paid | 0.297 | 0.035 | |||
已付現金利息 | 0 | ||||
其他投資現金流量項目,總計 | -215.438 | 28.705 | 75.791 | -200.901 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -59.309 | -221.102 | -168.526 | -110.489 | -51.894 |
Cash From Operating Activities | -50.997 | -5.853 | 32.005 | 72.418 | -38.869 |
Cash From Operating Activities | 1.664 | 6.075 | 4.177 | 2.668 | 1.224 |
Non-Cash Items | 11.588 | 54.004 | 39.511 | 26.72 | 12.665 |
Changes in Working Capital | -4.94 | 155.17 | 156.843 | 153.519 | -0.864 |
Cash From Investing Activities | 69.824 | -225.644 | -206.833 | -203.085 | -19.123 |
Capital Expenditures | -3.937 | -10.206 | -7.511 | -4.8 | -2.977 |
Other Investing Cash Flow Items, Total | 73.761 | -215.438 | -199.322 | -198.285 | -16.146 |
Cash From Financing Activities | 0.075 | 219.382 | 218.9 | 218.603 | 0.072 |
Financing Cash Flow Items | 0 | 0.895 | 0.477 | 0.477 | -0.068 |
Issuance (Retirement) of Stock, Net | 0.075 | 218.487 | 218.423 | 218.126 | 0.14 |
Net Change in Cash | 18.902 | -12.115 | 44.072 | 87.936 | -57.92 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
325 E Middlefield Rd
MOUNTAIN VIEW
CALIFORNIA 94043-4003
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易